WebHarrell's ProtectMAX Fluazinam Fungicide: 12/31/2024: Label PDF : N3923: 12: 228-623-52287: Harrell's ProtectMAX Propiconazole Fungicide: 12/31/2024: Label PDF : ... Webfortified with tebuconazole at levels of 0.05 and 5 mg/kg or at 0.05, 0.5 and 5 mg/kg. Single recoveries were in most cases within the 70–110% range, with one single value at 126% (plum). The limit of quantitation (LOQ) was 0.05 mg/kg. The relative standard deviation (RSD) of triplicate
5.25 TEBUCONAZOLE (189) RESIDUE AND ANALYTICAL …
WebPage 7/9 Safety Data Sheet acc. to OSHA HCS Printing date 09/01/2024 Revision date 09/01/2024 Trade name:Bifenthrin (Contd. from page 6) 53.1.21 · Sensitization:No sensitizing effects known. · Additional toxicological information: · Carcinogenic categories · IARC (International Agency for Research on Cancer)Substance is not listed. · NTP … Webtebuconazole Folicur, Toledo tetraconazole Mettle triazolinthione : prothioconazole . Proline, Prosaro, Stratego YLD 4 : phenylamide (PA) acylalanine : mefenoxam, … hyperprolactinemia antipsychotic
TEBUCONAZOLE (188) IDENTITY - Food and …
WebJan 15, 2015 · Spray Volume: Apply TEBUCONAZOLE 3.6F by ground in a minimum of 10 gallons of spray solution per acre or by air in a minimum of 5 gallons of spray solution per acre. Check equipment calibration frequently. For best disease control, complete coverage and uniform application are essential, especially when lower spray volumes are used. WebTebuconazole (Group 3) Formulation Type. Suspension Concentrate. Packaging. 6.07 L jug = 20 acres 97.17 L drum = 320 acres Return on Investment (ROI) ROI Relative to Untreated 1 + $51.77/ac. Estimated Net Revenue on 160 acres. $8,283. 1 Calculation based on. 32 Bayer Crop Science Internal Trials (2024) where the untreated check yielded 67.5 bu ... WebTreatments containing Premion (PCNB, tebuconazole) + Par SG (pigment), Oximus (azoxystrobin, tebuconazole), Ascernity (benzovindiflupyr, difenoconazole), or Mirage Stressgard (tebuconazole) exhibited the longest residual activity against BRP as evidenced by no disease activity at 69 days since previous treatment. ... hyperprolactinemia brain